• Focused on improving patient care

  • Quality matters
    Plasmasicherheit

  • Understanding the fragility and value of life

  • Developing future solutions for unmet patient needs


News

01.03.2018
Octapharma Group publishes 2017 annual results reporting revenue of €1.72 billion and operating income of €349 million

Lachen, Switzerland, March 1st, 2018: Over the last six years, the Octapharma Group has accomplished...

22.01.2018
Low inhibitor rate with octanate® in previously untreated patients (PUPs) with severe haemophilia A

Lachen, Switzerland, January 22nd, 2018: Octapharma is delighted to announce the publication of fina...